Development of apparatus and software for myocardial contrast echocardiography

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We can now perform myocardial contrast echocardiography (MCE) at bed-side with intravenous injection of Levovist. High mechanical index and triggered image are essential techniques to obtain myocardial contrast enhancement. Several imaging modalities, including harmonic-B, harmonic power Doppler, pulse inversion, ultraharmonic and 1.5 harmonic, are used to detect harmonic signals originating from microbubbles. MCE provides a noble technique for the diagnosis of myocardial infarction and ischemia as an area of hypo-enhancement or contrast defect. At present, however, there are several drawbacks with MCE that make the evaluation of MCE images difficult. Contrast enhancement is heterogeneous among myocardial segments in normal subjects and thus contrast defect does not necessarily imply any abnormality. This is because contrast enhancement is influenced by several factors, including concentration of microbubbles, acoustic power and so on. To resolve these problems, we have developed a new calibration method of MCE image. We hypothesized that we can reduce heterogeneity of contrast intensity and can estimate myocardial blood volume (MBV) by calibrating myocardial contrast amplitude (CA) to CA of the adjacent left ventricular (LV) cavity. Since CA is proportional to bubble concentration, we can estimate MBV by taking the ratio of myocardial CA to CA of the adjacent LV cavity. In normal segment, a mean of 14.5 dB reduction in myocardial CA from CA of 100% blood LV cavity, implies about 4 ml blood/100 g LV mass. In the infarct segments, there was a - 21 dB reduction from the LV cavity, implying <1 ml blood/100 g LV mass, and this was significantly lower than in normal segments. By making a color-coded map of calibrated myocardial CA, we can estimate spatial distribution of irreversibly damaged myocardium as a area of calibrated CA <- 18 dB. This new calibration method provides a simple and noninvasive estimate of MBV in the clinical setting. Measuring MBV provided useful estimates of myocardial viability in patients with myocardial infarction relatively independent of heterogeneity of acoustic fields.

Original languageEnglish
JournalJournal of Medical Ultrasonics
Volume30
Issue number4
Publication statusPublished - Jul 2003
Externally publishedYes

Fingerprint

Echocardiography
Blood Volume
Software
Microbubbles
Acoustics
Calibration
Myocardial Infarction
Intravenous Injections
Myocardial Ischemia
Myocardium
Color

Keywords

  • Contrast medium
  • Echocardiography
  • Microcirculation
  • Myocardial blood volume
  • Myocardial infarction

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Development of apparatus and software for myocardial contrast echocardiography. / Itoh, Hiroshi.

In: Journal of Medical Ultrasonics, Vol. 30, No. 4, 07.2003.

Research output: Contribution to journalArticle

@article{32390ff75a764535a9c1659a52303745,
title = "Development of apparatus and software for myocardial contrast echocardiography",
abstract = "We can now perform myocardial contrast echocardiography (MCE) at bed-side with intravenous injection of Levovist. High mechanical index and triggered image are essential techniques to obtain myocardial contrast enhancement. Several imaging modalities, including harmonic-B, harmonic power Doppler, pulse inversion, ultraharmonic and 1.5 harmonic, are used to detect harmonic signals originating from microbubbles. MCE provides a noble technique for the diagnosis of myocardial infarction and ischemia as an area of hypo-enhancement or contrast defect. At present, however, there are several drawbacks with MCE that make the evaluation of MCE images difficult. Contrast enhancement is heterogeneous among myocardial segments in normal subjects and thus contrast defect does not necessarily imply any abnormality. This is because contrast enhancement is influenced by several factors, including concentration of microbubbles, acoustic power and so on. To resolve these problems, we have developed a new calibration method of MCE image. We hypothesized that we can reduce heterogeneity of contrast intensity and can estimate myocardial blood volume (MBV) by calibrating myocardial contrast amplitude (CA) to CA of the adjacent left ventricular (LV) cavity. Since CA is proportional to bubble concentration, we can estimate MBV by taking the ratio of myocardial CA to CA of the adjacent LV cavity. In normal segment, a mean of 14.5 dB reduction in myocardial CA from CA of 100{\%} blood LV cavity, implies about 4 ml blood/100 g LV mass. In the infarct segments, there was a - 21 dB reduction from the LV cavity, implying <1 ml blood/100 g LV mass, and this was significantly lower than in normal segments. By making a color-coded map of calibrated myocardial CA, we can estimate spatial distribution of irreversibly damaged myocardium as a area of calibrated CA <- 18 dB. This new calibration method provides a simple and noninvasive estimate of MBV in the clinical setting. Measuring MBV provided useful estimates of myocardial viability in patients with myocardial infarction relatively independent of heterogeneity of acoustic fields.",
keywords = "Contrast medium, Echocardiography, Microcirculation, Myocardial blood volume, Myocardial infarction",
author = "Hiroshi Itoh",
year = "2003",
month = "7",
language = "English",
volume = "30",
journal = "Japanese Journal of Medical Ultrasonics",
issn = "1344-1388",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Development of apparatus and software for myocardial contrast echocardiography

AU - Itoh, Hiroshi

PY - 2003/7

Y1 - 2003/7

N2 - We can now perform myocardial contrast echocardiography (MCE) at bed-side with intravenous injection of Levovist. High mechanical index and triggered image are essential techniques to obtain myocardial contrast enhancement. Several imaging modalities, including harmonic-B, harmonic power Doppler, pulse inversion, ultraharmonic and 1.5 harmonic, are used to detect harmonic signals originating from microbubbles. MCE provides a noble technique for the diagnosis of myocardial infarction and ischemia as an area of hypo-enhancement or contrast defect. At present, however, there are several drawbacks with MCE that make the evaluation of MCE images difficult. Contrast enhancement is heterogeneous among myocardial segments in normal subjects and thus contrast defect does not necessarily imply any abnormality. This is because contrast enhancement is influenced by several factors, including concentration of microbubbles, acoustic power and so on. To resolve these problems, we have developed a new calibration method of MCE image. We hypothesized that we can reduce heterogeneity of contrast intensity and can estimate myocardial blood volume (MBV) by calibrating myocardial contrast amplitude (CA) to CA of the adjacent left ventricular (LV) cavity. Since CA is proportional to bubble concentration, we can estimate MBV by taking the ratio of myocardial CA to CA of the adjacent LV cavity. In normal segment, a mean of 14.5 dB reduction in myocardial CA from CA of 100% blood LV cavity, implies about 4 ml blood/100 g LV mass. In the infarct segments, there was a - 21 dB reduction from the LV cavity, implying <1 ml blood/100 g LV mass, and this was significantly lower than in normal segments. By making a color-coded map of calibrated myocardial CA, we can estimate spatial distribution of irreversibly damaged myocardium as a area of calibrated CA <- 18 dB. This new calibration method provides a simple and noninvasive estimate of MBV in the clinical setting. Measuring MBV provided useful estimates of myocardial viability in patients with myocardial infarction relatively independent of heterogeneity of acoustic fields.

AB - We can now perform myocardial contrast echocardiography (MCE) at bed-side with intravenous injection of Levovist. High mechanical index and triggered image are essential techniques to obtain myocardial contrast enhancement. Several imaging modalities, including harmonic-B, harmonic power Doppler, pulse inversion, ultraharmonic and 1.5 harmonic, are used to detect harmonic signals originating from microbubbles. MCE provides a noble technique for the diagnosis of myocardial infarction and ischemia as an area of hypo-enhancement or contrast defect. At present, however, there are several drawbacks with MCE that make the evaluation of MCE images difficult. Contrast enhancement is heterogeneous among myocardial segments in normal subjects and thus contrast defect does not necessarily imply any abnormality. This is because contrast enhancement is influenced by several factors, including concentration of microbubbles, acoustic power and so on. To resolve these problems, we have developed a new calibration method of MCE image. We hypothesized that we can reduce heterogeneity of contrast intensity and can estimate myocardial blood volume (MBV) by calibrating myocardial contrast amplitude (CA) to CA of the adjacent left ventricular (LV) cavity. Since CA is proportional to bubble concentration, we can estimate MBV by taking the ratio of myocardial CA to CA of the adjacent LV cavity. In normal segment, a mean of 14.5 dB reduction in myocardial CA from CA of 100% blood LV cavity, implies about 4 ml blood/100 g LV mass. In the infarct segments, there was a - 21 dB reduction from the LV cavity, implying <1 ml blood/100 g LV mass, and this was significantly lower than in normal segments. By making a color-coded map of calibrated myocardial CA, we can estimate spatial distribution of irreversibly damaged myocardium as a area of calibrated CA <- 18 dB. This new calibration method provides a simple and noninvasive estimate of MBV in the clinical setting. Measuring MBV provided useful estimates of myocardial viability in patients with myocardial infarction relatively independent of heterogeneity of acoustic fields.

KW - Contrast medium

KW - Echocardiography

KW - Microcirculation

KW - Myocardial blood volume

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=0042514967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042514967&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0042514967

VL - 30

JO - Japanese Journal of Medical Ultrasonics

JF - Japanese Journal of Medical Ultrasonics

SN - 1344-1388

IS - 4

ER -